Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?
In 2005, we performed the largest survey on clinical trials of biotherapies for all solid tumors and found indirect evidence of a publication bias: editors of medical journals were more prone to publish positive results independently from the quality of the studies. We collected data from 2003 to 20...
Main Authors: | Alessandro Ottaiano, Antonino Cassata, Monica Capozzi, Chiara De Divitiis, Alfonso De Stefano, Antonio Avallone |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fonc.2018.00062/full |
Similar Items
-
Biological behavior of Chrysomya putoria (Wiedemann, 1819) (Diptera: Calliphoridae) after refrigeration: Logistics for use in Biotherapy
by: DANIELE L. DALLAVECCHIA, et al.
Published: (2023-05-01) -
Treatment of non-systemic Sjögren's syndrome: Potential prevention of systematization with immunosuppressant agent/biotherapy
by: Aude Belbézier, et al.
Published: (2024-06-01) -
Single-Atom Catalysts for Biotherapy Applications: A Systematic Review
by: Shan Jiang, et al.
Published: (2020-12-01) -
cGAS-STING pathway in cancer biotherapy
by: Yang Wang, et al.
Published: (2020-09-01) -
Biotherapy for and protection against gastrointestinal pathogenic infections via action of probiotic bacteria
by: Mongkol Thirabunyanon
Published: (2011-03-01)